The stanley foundation bipolar network

R. M. Post, W. A. Nolen, R. W. Kupka, K. D. Denicoff, G. S. Leverich, Jr Keck P.E., S. L. McElroy, A. J. Rush, T. Suppes, L. L. Altshuler, Mark A Frye, H. Grunze, J. Walden

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Background The Stanley Foundation Bipolar Network (SFBN) was created to address the paucity of help studies in bipolar illness. Aims To describe the rationale and methods of the SFBN. Method The SFBN includes five core sites and a number of affiliated sites that have adopted consistent methodology for continuous longitudinal monitoring of patients. Open and controlled studies are performed as patients' symptomatology dictates. Results The reliability of SFBN raters and the validity of the rating instruments have been established. More than 500 patients are in continuous daily longitudinal follow-up. More than 125 have been randomised to one of three of the newer antidepressants (bupropion, sertraline and venlafaxine) as adjuncts in a study of mood stabilisers and 93 to omega-3 fatty acids. A number of open clinical case series have been published. Conclusions Well-characterised patients are followed in a detailed continuous longitudinal fashion in both opportunistic case series and double-blind, randomised controlled trials with reliable and validated measures. Declaration of interest Support received from the Theodore and Vada Stanley Foundation.

Original languageEnglish (US)
JournalBritish Journal of Psychiatry
Volume178
Issue numberSUPPL. 141
StatePublished - 2001
Externally publishedYes

Fingerprint

Bupropion
Sertraline
Omega-3 Fatty Acids
Physiologic Monitoring
Reproducibility of Results
Antidepressive Agents
Randomized Controlled Trials
Venlafaxine Hydrochloride

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Post, R. M., Nolen, W. A., Kupka, R. W., Denicoff, K. D., Leverich, G. S., Keck P.E., J., ... Walden, J. (2001). The stanley foundation bipolar network. British Journal of Psychiatry, 178(SUPPL. 141).

The stanley foundation bipolar network. / Post, R. M.; Nolen, W. A.; Kupka, R. W.; Denicoff, K. D.; Leverich, G. S.; Keck P.E., Jr; McElroy, S. L.; Rush, A. J.; Suppes, T.; Altshuler, L. L.; Frye, Mark A; Grunze, H.; Walden, J.

In: British Journal of Psychiatry, Vol. 178, No. SUPPL. 141, 2001.

Research output: Contribution to journalArticle

Post, RM, Nolen, WA, Kupka, RW, Denicoff, KD, Leverich, GS, Keck P.E., J, McElroy, SL, Rush, AJ, Suppes, T, Altshuler, LL, Frye, MA, Grunze, H & Walden, J 2001, 'The stanley foundation bipolar network', British Journal of Psychiatry, vol. 178, no. SUPPL. 141.
Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck P.E. J et al. The stanley foundation bipolar network. British Journal of Psychiatry. 2001;178(SUPPL. 141).
Post, R. M. ; Nolen, W. A. ; Kupka, R. W. ; Denicoff, K. D. ; Leverich, G. S. ; Keck P.E., Jr ; McElroy, S. L. ; Rush, A. J. ; Suppes, T. ; Altshuler, L. L. ; Frye, Mark A ; Grunze, H. ; Walden, J. / The stanley foundation bipolar network. In: British Journal of Psychiatry. 2001 ; Vol. 178, No. SUPPL. 141.
@article{57425192f4d6415e904f521c7a50c03e,
title = "The stanley foundation bipolar network",
abstract = "Background The Stanley Foundation Bipolar Network (SFBN) was created to address the paucity of help studies in bipolar illness. Aims To describe the rationale and methods of the SFBN. Method The SFBN includes five core sites and a number of affiliated sites that have adopted consistent methodology for continuous longitudinal monitoring of patients. Open and controlled studies are performed as patients' symptomatology dictates. Results The reliability of SFBN raters and the validity of the rating instruments have been established. More than 500 patients are in continuous daily longitudinal follow-up. More than 125 have been randomised to one of three of the newer antidepressants (bupropion, sertraline and venlafaxine) as adjuncts in a study of mood stabilisers and 93 to omega-3 fatty acids. A number of open clinical case series have been published. Conclusions Well-characterised patients are followed in a detailed continuous longitudinal fashion in both opportunistic case series and double-blind, randomised controlled trials with reliable and validated measures. Declaration of interest Support received from the Theodore and Vada Stanley Foundation.",
author = "Post, {R. M.} and Nolen, {W. A.} and Kupka, {R. W.} and Denicoff, {K. D.} and Leverich, {G. S.} and {Keck P.E.}, Jr and McElroy, {S. L.} and Rush, {A. J.} and T. Suppes and Altshuler, {L. L.} and Frye, {Mark A} and H. Grunze and J. Walden",
year = "2001",
language = "English (US)",
volume = "178",
journal = "British Journal of Psychiatry",
issn = "0007-1250",
publisher = "Royal College of Psychiatrists",
number = "SUPPL. 141",

}

TY - JOUR

T1 - The stanley foundation bipolar network

AU - Post, R. M.

AU - Nolen, W. A.

AU - Kupka, R. W.

AU - Denicoff, K. D.

AU - Leverich, G. S.

AU - Keck P.E., Jr

AU - McElroy, S. L.

AU - Rush, A. J.

AU - Suppes, T.

AU - Altshuler, L. L.

AU - Frye, Mark A

AU - Grunze, H.

AU - Walden, J.

PY - 2001

Y1 - 2001

N2 - Background The Stanley Foundation Bipolar Network (SFBN) was created to address the paucity of help studies in bipolar illness. Aims To describe the rationale and methods of the SFBN. Method The SFBN includes five core sites and a number of affiliated sites that have adopted consistent methodology for continuous longitudinal monitoring of patients. Open and controlled studies are performed as patients' symptomatology dictates. Results The reliability of SFBN raters and the validity of the rating instruments have been established. More than 500 patients are in continuous daily longitudinal follow-up. More than 125 have been randomised to one of three of the newer antidepressants (bupropion, sertraline and venlafaxine) as adjuncts in a study of mood stabilisers and 93 to omega-3 fatty acids. A number of open clinical case series have been published. Conclusions Well-characterised patients are followed in a detailed continuous longitudinal fashion in both opportunistic case series and double-blind, randomised controlled trials with reliable and validated measures. Declaration of interest Support received from the Theodore and Vada Stanley Foundation.

AB - Background The Stanley Foundation Bipolar Network (SFBN) was created to address the paucity of help studies in bipolar illness. Aims To describe the rationale and methods of the SFBN. Method The SFBN includes five core sites and a number of affiliated sites that have adopted consistent methodology for continuous longitudinal monitoring of patients. Open and controlled studies are performed as patients' symptomatology dictates. Results The reliability of SFBN raters and the validity of the rating instruments have been established. More than 500 patients are in continuous daily longitudinal follow-up. More than 125 have been randomised to one of three of the newer antidepressants (bupropion, sertraline and venlafaxine) as adjuncts in a study of mood stabilisers and 93 to omega-3 fatty acids. A number of open clinical case series have been published. Conclusions Well-characterised patients are followed in a detailed continuous longitudinal fashion in both opportunistic case series and double-blind, randomised controlled trials with reliable and validated measures. Declaration of interest Support received from the Theodore and Vada Stanley Foundation.

UR - http://www.scopus.com/inward/record.url?scp=17044450885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17044450885&partnerID=8YFLogxK

M3 - Article

C2 - 11450179

AN - SCOPUS:17044450885

VL - 178

JO - British Journal of Psychiatry

JF - British Journal of Psychiatry

SN - 0007-1250

IS - SUPPL. 141

ER -